These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 31017086)

  • 21. Blood-Based Biomarkers as Prognostic Factors of Recurrent Disease after Radical Cystectomy: A Systematic Review and Meta-Analysis.
    Ofner H; Laukhtina E; Hassler MR; Shariat SF
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the prognosis of primary and progressive muscle-invasive bladder cancer after radical cystectomy: A systematic review and meta-analysis.
    Chen J; Zhang H; Sun G; Zhang X; Zhao J; Liu J; Shen P; Shi M; Zeng H
    Int J Surg; 2018 Apr; 52():214-220. PubMed ID: 29496649
    [TBL] [Abstract][Full Text] [Related]  

  • 23. National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004-2013.
    Bateni ZH; Pearce SM; Zainfeld D; Ballas L; Djaladat H; Schuckman AK; Daneshmand S
    Eur Urol Oncol; 2020 Jun; 3(3):343-350. PubMed ID: 31317867
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Systematic review and cumulative analysis of perioperative outcomes and complications after robot-assisted radical cystectomy.
    Novara G; Catto JW; Wilson T; Annerstedt M; Chan K; Murphy DG; Motttrie A; Peabody JO; Skinner EC; Wiklund PN; Guru KA; Yuh B
    Eur Urol; 2015 Mar; 67(3):376-401. PubMed ID: 25560798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of neoadjuvant chemotherapy on perioperative outcomes in patients who have bladder cancer treated with radical cystectomy: a population-based study.
    Gandaglia G; Popa I; Abdollah F; Schiffmann J; Shariat SF; Briganti A; Montorsi F; Trinh QD; Karakiewicz PI; Sun M
    Eur Urol; 2014 Sep; 66(3):561-8. PubMed ID: 24486024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Population-based trends in urinary diversion among patients undergoing radical cystectomy for bladder cancer.
    Kim SP; Shah ND; Weight CJ; Thompson RH; Wang JK; Karnes RJ; Han LC; Ziegenfuss JY; Frank I; Tollefson MK; Boorjian SA
    BJU Int; 2013 Aug; 112(4):478-84. PubMed ID: 23452020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphadenectomy for bladder cancer at the time of radical cystectomy.
    Tilki D; Brausi M; Colombo R; Evans CP; Fradet Y; Fritsche HM; Lerner SP; Sagalowsky A; Shariat SF; Bochner BH
    Eur Urol; 2013 Aug; 64(2):266-76. PubMed ID: 23648149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Location of Metastatic Bladder Cancer as a Determinant of In-hospital Mortality After Radical Cystectomy.
    Zaffuto E; Bandini M; Moschini M; Leyh-Bannurah SR; Gazdovich S; Dell'Oglio P; Gallina A; Shariat SF; Briganti A; Montorsi F; Saad F; Karakiewicz PI
    Eur Urol Oncol; 2018 Jun; 1(2):169-175. PubMed ID: 31100242
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impact of enhanced recovery after surgery protocols versus standard of care on perioperative outcomes of radical cystectomy: a systematic review and meta-analysis of comparative studies.
    Giannarini G; Crestani A; Inferrera A; Rossanese M; Subba E; Novara G; Ficarra V
    Minerva Urol Nefrol; 2019 Aug; 71(4):309-323. PubMed ID: 31241271
    [TBL] [Abstract][Full Text] [Related]  

  • 30. ICUD-EAU International Consultation on Bladder Cancer 2012: Radical cystectomy and bladder preservation for muscle-invasive urothelial carcinoma of the bladder.
    Gakis G; Efstathiou J; Lerner SP; Cookson MS; Keegan KA; Guru KA; Shipley WU; Heidenreich A; Schoenberg MP; Sagaloswky AI; Soloway MS; Stenzl A;
    Eur Urol; 2013 Jan; 63(1):45-57. PubMed ID: 22917985
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Correlates of refusal of radical cystectomy in patients with muscle-invasive bladder cancer.
    Elshabrawy A; Wang H; Satsangi A; Wheeler K; Ramamurthy C; Pruthi D; Kaushik D; Liss M; Gelfond J; Fernandez R; Gore J; Svatek R; Mansour AM
    Urol Oncol; 2021 Apr; 39(4):236.e9-236.e20. PubMed ID: 33423936
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Delays in radical cystectomy for muscle-invasive bladder cancer.
    Chu AT; Holt SK; Wright JL; Ramos JD; Grivas P; Yu EY; Gore JL
    Cancer; 2019 Jun; 125(12):2011-2017. PubMed ID: 30840335
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A;
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors of costs associated with radical cystectomy for bladder cancer: A population-based retrospective cohort study in the province of Quebec, Canada.
    Santos F; Dragomir A; Zakaria AS; Kassouf W; Aprikian A
    J Surg Oncol; 2016 Feb; 113(2):223-8. PubMed ID: 26696270
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systematic review and cumulative analysis of oncologic and functional outcomes after robot-assisted radical cystectomy.
    Yuh B; Wilson T; Bochner B; Chan K; Palou J; Stenzl A; Montorsi F; Thalmann G; Guru K; Catto JW; Wiklund PN; Novara G
    Eur Urol; 2015 Mar; 67(3):402-22. PubMed ID: 25560797
    [TBL] [Abstract][Full Text] [Related]  

  • 36. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
    Witjes JA; Bruins HM; Cathomas R; Compérat EM; Cowan NC; Gakis G; Hernández V; Linares Espinós E; Lorch A; Neuzillet Y; Rouanne M; Thalmann GN; Veskimäe E; Ribal MJ; van der Heijden AG
    Eur Urol; 2021 Jan; 79(1):82-104. PubMed ID: 32360052
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High hospital and surgeon volume and its impact on overall survival after radical cystectomy among patients with bladder cancer in Quebec.
    Santos F; Zakaria AS; Kassouf W; Tanguay S; Aprikian A
    World J Urol; 2015 Sep; 33(9):1323-30. PubMed ID: 25471670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The impact of the extent of lymphadenectomy on oncologic outcomes in patients undergoing radical cystectomy for bladder cancer: a systematic review.
    Bruins HM; Veskimae E; Hernandez V; Imamura M; Neuberger MM; Dahm P; Stewart F; Lam TB; N'Dow J; van der Heijden AG; Compérat E; Cowan NC; De Santis M; Gakis G; Lebret T; Ribal MJ; Sherif A; Witjes JA
    Eur Urol; 2014 Dec; 66(6):1065-77. PubMed ID: 25074764
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Minimally Invasive Versus Open Approach for Cystectomy: Trends in the Utilization and Demographic or Clinical Predictors Using the National Cancer Database.
    Bachman AG; Parker AA; Shaw MD; Cross BW; Stratton KL; Cookson MS; Patel SG
    Urology; 2017 May; 103():99-105. PubMed ID: 28214574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.